Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02513472
Brief Title: Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) (ENHANCE-1)

First Submitted : July 29, 2015
First Submitted that Met QC Criteria : July 30, 2015
First Posted : July 31, 2015 (Estimate)

Results First Submitted : July 29, 2020
Results First Submitted that Met QC Criteria : July 29, 2020
Results First Posted : August 14, 2020

Last Update Submitted that Met QC Criteria : July 29, 2020
Last Update Posted : August 14, 2020